SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-013807
Filing Date
2018-11-06
Accepted
2018-11-06 17:18:26
Documents
85
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-09302018.htm 10-Q 1293107
2 EXHIBIT 31.1 exhibit311-09302018.htm EX-31.1 13550
3 EXHIBIT 31.2 exhibit312-09302018.htm EX-31.2 13558
4 EXHIBIT 32.1 exhibit321-09302018.htm EX-32.1 8790
5 EXHIBIT 32.2 exhibit322-09302018.htm EX-32.2 8806
  Complete submission text file 0001628280-18-013807.txt   7804538

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20180930.xml EX-101.INS 1800554
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20180930.xsd EX-101.SCH 56484
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20180930_cal.xml EX-101.CAL 92004
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20180930_def.xml EX-101.DEF 231959
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20180930_lab.xml EX-101.LAB 733445
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20180930_pre.xml EX-101.PRE 437629
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 181163962
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1